Does GLYCOPYRRONIUM Cause Off label use? 166 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 166 reports of Off label use have been filed in association with GLYCOPYRRONIUM (Qbrexza). This represents 12.6% of all adverse event reports for GLYCOPYRRONIUM.
166
Reports of Off label use with GLYCOPYRRONIUM
12.6%
of all GLYCOPYRRONIUM reports
0
Deaths
4
Hospitalizations
How Dangerous Is Off label use From GLYCOPYRRONIUM?
Of the 166 reports, 4 (2.4%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLYCOPYRRONIUM. However, 166 reports have been filed with the FAERS database.
What Other Side Effects Does GLYCOPYRRONIUM Cause?
Mydriasis (280)
Dry mouth (237)
Asthma (227)
Dyspnoea (225)
Vision blurred (182)
Drug ineffective (125)
Wheezing (120)
Urinary retention (105)
Cough (103)
Intentional product misuse (95)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which GLYCOPYRRONIUM Alternatives Have Lower Off label use Risk?
GLYCOPYRRONIUM vs GLYCOPYRRONIUM\INDACATEROL
GLYCOPYRRONIUM vs GOLD
GLYCOPYRRONIUM vs GOLD THIOMALATE
GLYCOPYRRONIUM vs GOLIMUMAB
GLYCOPYRRONIUM vs GOLODIRSEN